--- title: "AXIM BIOTECHNOLOGIES, INC. (AXIM) stock and investor profile" url: "https://aibio.space/companies/axim-biotechnologies/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "AXIM BIOTECHNOLOGIES, INC. (OTC: AXIM), United States. Listing facts, related biotech companies and news on aibio.space." --- AXIM AXIM BIOTECHNOLOGIES, INC. OTC · United States # AXIM BIOTECHNOLOGIES, INC. (AXIM) news AXIM BIOTECHNOLOGIES, INC. is a public biotech or pharmaceutical company listed on OTC under the ticker AXIM, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. ## Latest AXIM BIOTECHNOLOGIES, INC. news We have not published a story on AXIM BIOTECHNOLOGIES, INC. yet. When there is news, it will appear here. ## AXIM BIOTECHNOLOGIES, INC. at a glance - **Ticker**: AXIM - **Listing**: OTC - **Country**: United States - **Cash, Jun 30, 2024**: $6,044 ### Related companies - [Axogen](https://aibio.space/companies/axogen/) NASDAQ: AXGN - [TELA Bio](https://aibio.space/companies/tela-bio/) NASDAQ: TELA - [Autonomix Medical](https://aibio.space/companies/autonomix-medical/) NASDAQ: AMIX - [Nok Therapeutics](https://aibio.space/companies/nok-therapeutics/) OTC: NKTPD - [Cresco Labs](https://aibio.space/companies/cresco-labs/) OTC: CRLBF - [Brainsway](https://aibio.space/companies/brainsway/) NASDAQ: BWAY - [One World Products](https://aibio.space/companies/one-world-products/) OTC: OWPC - [DarioHealth](https://aibio.space/companies/dariohealth/) NASDAQ: DRIO ### Also on OTC - [Provectus Biopharmaceuticals](https://aibio.space/companies/provectus-biopharmaceuticals/) PVCT - [EAGLE PHARMACEUTICALS INC](https://aibio.space/companies/eagle-pharmaceuticals/) EGRX - [Manhattan Scientifics](https://aibio.space/companies/manhattan-scientifics/) MHTX - [ENDONOVO THERAPEUTICS, INC.](https://aibio.space/companies/endonovo-therapeutics/) ENDV - [Curaleaf Holdings](https://aibio.space/companies/curaleaf/) CURLF - [Amarantus Bioscience Holdings](https://aibio.space/companies/amarantus-bioscience/) AMBS ## AXIM BIOTECHNOLOGIES, INC. annual financials | Line | FY2023 | FY2022 | |---|---|---| | Revenue | [$39,518](https://www.sec.gov/Archives/edgar/data/1514946/000109690624000864/) | [$8,875](https://www.sec.gov/Archives/edgar/data/1514946/000109690624000864/) | | Research and development | [$125,496](https://www.sec.gov/Archives/edgar/data/1514946/000109690624000864/) | [$153,697](https://www.sec.gov/Archives/edgar/data/1514946/000109690624000864/) | | Net income (loss) | [-$8.1 million](https://www.sec.gov/Archives/edgar/data/1514946/000109690624000864/) | [-$6.2 million](https://www.sec.gov/Archives/edgar/data/1514946/000109690624000864/) | | Cash from operations | [-$1.0 million](https://www.sec.gov/Archives/edgar/data/1514946/000109690624000864/) | [-$2.0 million](https://www.sec.gov/Archives/edgar/data/1514946/000109690624000864/) | | Cash and equivalents | [$156,457](https://www.sec.gov/Archives/edgar/data/1514946/000109690624001772/) | [$47,282](https://www.sec.gov/Archives/edgar/data/1514946/000109690623001168/) | Latest balance sheet, Jun 30, 2024 (10-Q): cash and equivalents $6,044. Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice. ## Questions about AXIM BIOTECHNOLOGIES, INC. What is the ticker symbol of AXIM BIOTECHNOLOGIES, INC.? AXIM BIOTECHNOLOGIES, INC. trades under the ticker AXIM on OTC. Where is AXIM BIOTECHNOLOGIES, INC. listed? AXIM BIOTECHNOLOGIES, INC. is listed on OTC. Which country or territory is AXIM BIOTECHNOLOGIES, INC. listed under? Our directory records AXIM BIOTECHNOLOGIES, INC. under United States. Does aibio.space cover AXIM BIOTECHNOLOGIES, INC.? aibio.space lists AXIM BIOTECHNOLOGIES, INC. among 2,820 public biotech companies and publishes its news here as stories appear. What was AXIM BIOTECHNOLOGIES, INC.'s revenue last year? $39,518 for the fiscal year ended Dec 31, 2023, as reported to the SEC. Is AXIM BIOTECHNOLOGIES, INC. profitable? AXIM BIOTECHNOLOGIES, INC. reported a net loss of $8.1 million for the fiscal year ended Dec 31, 2023, and used $1.0 million of cash in operations, per its annual report to the SEC. How much does AXIM BIOTECHNOLOGIES, INC. spend on research and development? $125,496 in the fiscal year ended Dec 31, 2023, per its annual report. How much cash does AXIM BIOTECHNOLOGIES, INC. have? $6,044 in cash at Jun 30, 2024, per its 10-Q. ## Investor discussion: AXIM BIOTECHNOLOGIES, INC. Members talk about AXIM BIOTECHNOLOGIES, INC. (AXIM). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open OTC:AXIM on TradingView](https://www.tradingview.com/symbols/OTC-AXIM/). ## Listing details AXIM BIOTECHNOLOGIES, INC. is a public biotech or pharmaceutical company listed on OTC under the ticker AXIM, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: AXIM BIOTECHNOLOGIES, INC. - **Ticker**: AXIM - **Listing**: OTC - **Country or territory**: United States Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/axim-biotechnologies/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "AXIM BIOTECHNOLOGIES, INC. (AXIM) stock and investor profile", 2026-10-31, https://aibio.space/companies/axim-biotechnologies/